Watch Demo

Sweden Anti Rheumatic Industry Outlook 2022 - 2026

See how Sweden Anti Rheumatic performed compared to key markets such as South Korea, Germany and Spain.

Key Market Indicators

Swedish antirheumatic medicine sales are forecast to drop to $74 million by 2026. The market has decreased by an average of 1.2% year on year since 2021, when it stood at $79.3 million. This represents a 3.2% drop since 2005. The Czech Republic overtook Sweden in 2021 with sales of $79.3 million, and Germany, Spain, and Canada ranked second, third, and fourth respectively.

Marketing Banner

Sweden Anti Rheumatic Market Data and Forecasts

How much will Sweden Anti Rheumatic Market grow to 2026?

Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
More in Anti Rheumatic Industry for 2028

Improve your Knowledge with the latest Indicators and Trends